Acadian Asset Management LLC Cidara Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

$28.7 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.75 - $1.98 $236,271 - $623,755	-315,028 Reduced 25.07%	941,574 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$0.48 - $0.76 $20,674 - $32,733	43,071 Added 3.55%	1,256,602 $948,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.81 $44,412 - $79,942	98,694 Added 8.85%	1,213,531 $760,000
Q2 2022 Aug 09, 2022	BUY	$0.43 - $0.91 $6,681 - $14,139	15,538 Added 1.41%	1,114,837 $545,000
Q1 2022 May 12, 2022	BUY	$0.67 - $1.39 $140,586 - $291,663	209,830 Added 23.59%	1,099,299 $914,000

Q4 2021 Feb 10, 2022	BUY	$1.18 - $2.18 $357,092 - $659,713	302,621 Added 51.57%	889,469 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$1.48 - $2.35 $239,573 - $380,403	161,874 Added 38.09%	586,848 $1.31 Million
Q2 2021 Aug 11, 2021	BUY	$1.87 - $2.7 $253,048 - $365,364	135,320 Added 46.72%	424,974 $859,000
Q1 2021 May 11, 2021	SELL	$2.06 - $3.01 $90,613 - $132,400	-43,987 Reduced 13.18%	289,654 $770,000
Q4 2020 Feb 11, 2021	BUY	$1.99 - $3.25 $2,135 - $3,487	1,073 Added 0.32%	333,641 $668,000
Q3 2020 Nov 09, 2020	BUY	$2.85 - $4.1 $189,946 - $273,256	66,648 Added 25.06%	332,568 $948,000
Q2 2020 Aug 12, 2020	BUY	$2.39 - $4.0 $190,494 - $318,820	79,705 Added 42.8%	265,920 $981,000
Q1 2020 May 11, 2020	BUY	$1.74 - $4.26 $195,231 - $477,980	112,202 Added 151.6%	186,215 $462,000
Q4 2019 Feb 06, 2020	BUY	$1.77 - $3.84 $131,003 - $284,209	74,013 New	74,013 $284,000
Q3 2019 Nov 07, 2019	SELL	$1.25 - $2.35 $82,355 - $154,827	-65,884 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$1.49 - $2.94 $13,147 - $25,942	-8,824 Reduced 11.81%	65,884 $111,000
Q1 2019 May 09, 2019	SELL	$2.35 - $3.27 $15,557 - $21,647	-6,620 Reduced 8.14%	74,708 $198,000
Q3 2018 Oct 30, 2018	SELL	$3.7 - $5.25 $19,191 - $27,231	-5,187 Reduced 6.0%	81,328 $358,000
Q2 2018 Jul 24, 2018	BUY	$3.75 - $6.05 $172,571 - $278,414	46,019 Added 113.64%	86,515 $450,000
Q1 2018 Apr 12, 2018	BUY	$4.0 - $8.15 $161,984 - $330,042	40,496 New	40,496 $162,000

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.1M

Call Options Held

2.7K

Put Options Held

100

Bvf Inc San Francisco, CA

6.86M
Shares

$87.1 Million
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

3.35M
Shares

$42.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.55M
Shares

$32.4 Million
0.0% of portfolio
Alethea Capital Management, LLC San Diego, CA

1.6M
Shares

$20.3 Million
1.21% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

1.25M
Shares

$15.9 Million
0.0% of portfolio

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account